BioSpace News Archive

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke, today announced that the company will deliver a presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference, which is being held September 16-19, 2022, at the Boston Convention and Exhibition Center in Boston, MA.

Akero Therapeutics, Inc., a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced that it has commenced an underwritten public offering of $175.0 million of shares of its common stock.

The latest market analysis report published by Reports and Data, titled ‘Global Erythematosus Market – Forecast to 2030,’ thoroughly examines the Erythematosus industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Diabetic Ketoacidosis Market – Forecast to 2030,’ thoroughly examines the Diabetic Ketoacidosis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Advanced Renal Cell Carcinoma Market – Forecast to 2030,’ thoroughly examines the Advanced Renal Cell Carcinoma industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Anterior Uveitis Market – Forecast to 2030,’ thoroughly examines the Anterior Uveitis industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Bile Duct Cancer Market – Forecast to 2030,’ thoroughly examines the Bile Duct Cancer industry to provide essential data & information for the targeted readers.

Fusion Pharmaceuticals Inc. announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 197,200 shares of its common stock to 10 employees outside Fusion’s 2020 Stock Option and Incentive Plan.

The latest market analysis report published by Reports and Data, titled ‘Global Charcot Marie Tooth Disease Market – Forecast to 2030,’ thoroughly examines the Charcot Marie Tooth Disease industry to provide essential data & information for the targeted readers.

The recent study of Reports and Data on the suggests that the Neurodiagnostics market will be valued at USD 27.10 billion, growing at a CAGR of 7.8%.